Gene · 7538
Papers2,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases. | Signal Transduct Target Ther | 2023 | 38072908 | PubTator, text mining | PubMed |
| The DNA glycosylase NEIL2 is protective during SARS-CoV-2 infection. | Nat Commun | 2023 | 38071370 | PubTator, text mining | PubMed |
| Hypoxic Effects on Matrix Metalloproteinases' Expression in the Tumor Microenvironment and Therapeutic Perspectives. | Int J Mol Sci | 2023 | 38069210 | PubTator, text mining | PubMed |
| Single-cell transcriptomics reveals variations in monocytes and Tregs between gout flare and remission. | JCI Insight | 2023 | 38063198 | PubTator, text mining | PubMed |
| The recent advancements of ferroptosis in the diagnosis, treatment and prognosis of ovarian cancer. | Front Genet | 2023 | 38028615 | PubTator, text mining | PubMed |
| Competing endogenous RNAs in human astrocytes: crosstalk and interacting networks in response to lipotoxicity. | Front Neurosci | 2023 | 38027526 | PubTator, text mining | PubMed |
| Editorial: Diabetic renal tubulointerstitial disease. | Front Endocrinol (Lausanne) | 2023 | 38027121 | PubTator, text mining | PubMed |
| A new ferroptosis-related signature model including messenger RNAs and long non-coding RNAs predicts the prognosis of gastric cancer patients. | J Transl Int Med | 2023 | 38025952 | PubTator, text mining | PubMed |
| Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition. | iScience | 2023 | 38025778 | PubTator, text mining | PubMed |
| The SYSCID map: a graphical and computational resource of molecular mechanisms across rheumatoid arthritis, systemic lupus erythematosus and inflammatory bowel disease. | Front Immunol | 2023 | 38022524 | PubTator, text mining | PubMed |
| Identification of A Novel Gene Signature Combining Ferroptosis- and Immunity-Related Genes for Prognostic Prediction, Immunotherapy and Potential Therapeutic Targets in Gastric Cancer. | J Cancer | 2023 | 38021154 | PubTator, text mining | PubMed |
| From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning. | Mil Med Res | 2023 | 38017571 | PubTator, text mining | PubMed |
| Increased spatial coupling of integrin and collagen IV in the immunoresistant clear cell renal cell carcinoma tumor microenvironment. | bioRxiv | 2023 | 38014063 | PubTator, text mining | PubMed |
| Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer. | Pharmaceuticals (Basel) | 2023 | 38004379 | PubTator, text mining | PubMed |
| Development of a Comprehensive Gene Signature Linking Hypoxia, Glycolysis, Lactylation, and Metabolomic Insights in Gastric Cancer through the Integration of Bulk and Single-Cell RNA-Seq Data. | Biomedicines | 2023 | 38001949 | PubTator, text mining | PubMed |
| Heme Oxygenase-1 and Its Role in Colorectal Cancer. | Antioxidants (Basel) | 2023 | 38001842 | PubTator, text mining | PubMed |
| Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition. | Biochem Pharmacol | 2023 | 37989415 | PubTator, text mining | PubMed |
| Investigating EGF and PAG1 as necroptosis-related biomarkers for diabetic nephropathy: an in silico and in vitro validation study. | Aging (Albany NY) | 2023 | 37988198 | PubTator, text mining | PubMed |
| Splicing under stress: A matter of time and place. | J Cell Biol | 2023 | 37988026 | PubTator, text mining | PubMed |
| Associations of early pregnancy serum uric acid levels with risk of gestational diabetes and birth outcomes: a retrospective cohort study. | BMC Endocr Disord | 2023 | 37985985 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7538/papers?page=13